Essex Investment Management’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-4,093
Closed -$1.06M 470
2019
Q2
$1.06M Buy
+4,093
New +$820K 0.15% 213

Other funds holding CDLX

Essex Investment Management's CDLX Position: Q3 2019 in Review

Essex Investment Management sold out of Cardlytics (CDLX) in Q3 2019, closing a stake of 4,093 shares — an estimated $1.06M sold.

Essex Investment Management first reported a position in CDLX in Q2 2019 and held it in 1 quarter. The position peaked at $1.06M in Q2 2019. 117 funds tracked by Wall St. Rank hold CDLX as of Q3 2019.

  • Essex Investment Management reported no remaining Cardlytics position as of Q3 2019 after selling out during the quarter.
  • Essex Investment Management sold 4,093 Cardlytics shares in Q3 2019, an estimated $1.06M.
  • Essex Investment Management first reported a position in Cardlytics in Q2 2019 and held it in 1 quarter.
  • Essex Investment Management's Cardlytics position peaked at $1.06M in Q2 2019.
  • 117 funds tracked by Wall St. Rank held Cardlytics as of Q3 2019.

Based on Essex Investment Management's 13F filing for Q3 2019, filed 22 Oct 2019.